Autologous serum therapy in chronic urticaria: A promising complement to antihistamines | Zendy

NilayKanti Das | Zendy; Panchami Debbarman | Zendy; Amrita Sil | Zendy; PiyushKanti Datta | Zendy; Debabrata Bandyopadhyay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Autologous serum therapy in chronic urticaria: A promising complement to antihistamines

Author(s) -

NilayKanti Das,

Panchami Debbarman,

Amrita Sil,

PiyushKanti Datta,

Debabrata Bandyopadhyay

Publication year - 2014

Publication title -

indian journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 36

eISSN - 1998-3611

pISSN - 0019-5154

DOI - 10.4103/0019-5154.135490

Subject(s) - medicine , cetirizine , dermatology life quality index , placebo , group b , adverse effect , antihistamine , chronic urticaria , randomized controlled trial , pill , group a , gastroenterology , anesthesia , pharmacology , pathology , alternative medicine , disease

Chronic urticaria (CU) is a vexing problem and patients of CU suffer from the morbidity that arise from irritable itch and weals and are also subjected to a huge antihistamine pill burden. The symptoms are more in autoreactive urticaria (AU) where auto-antibodies in blood flares-up the condition. Search for newer effective modalities which can reduce pill burden is a felt need.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research